Clinical Trial Update: EBUS-TBNA Versus EBUS-TBNB [NA]

View source ↗

Summary

A clinical trial comparing EBUS-TBNA to EBUS-TBNB has been withdrawn from the registry, per the sponsor Royal Brompton & Harefield NHS Foundation Trust.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma
• Hilar Lymphadenopathy
• Lymphoma
• Mediastinal Lymphadenopathy
• Mycobacterial Disease
• Sarcoidosis

Snippet

Sponsor: Royal Brompton & Harefield NHS Foundation Trust | Conditions: Mediastinal Lymphadenopathy, Hilar Lymphadenopathy | NA | Status: WITHDRAWN